Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition

Publication date: Available online 17 March 2021Source: Biochimica et Biophysica Acta (BBA) - Molecular Cell ResearchAuthor(s): Cheng-Yi Wang, Meng-Hsuan Lee, Yu-Rung Kao, Shih-Hsin Hsiao, Shiao-Ya Hong, Cheng-Wen Wu
Source: Biochimica et Biophysica Acta (BBA) Molecular Cell Research - Category: Molecular Biology Source Type: research
More News: Men | Molecular Biology